HOME >> BIOLOGY >> NEWS
Low doses of radiation in nature may pose more risk

NEW YORK, NY Radiation can trigger widespread mutations in living cells at much lower doses than the amount scientists previously believed could do such damage, according to findings from a study by Columbia researchers. The research may help public health officials reconsider what levels of radiation in nature should be deemed safe.

Led by professor of radiation oncology and public health Dr. Tom K. Hei, the study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic (mutation-causing) effect as a dose that strikes every cell. The added damage occurs, the researchers say, because of what is called the bystander effect, in which injured cells send aberrant signals to neighboring cells. The study is to be published in the Dec. 4th issue of the Proceedings of the National Academy of Science.

The researchers found the bystander effect occurs with alpha particles, a common type of radiation that comes from sources such as nuclear explosions, plutonium, and radon, a naturally occurring gas that seeps into many homes.

In the National Cancer Institute-funded study, the researchers beamed a single alpha particle through the nuclei of randomly selected cells growing in petri dishes. Alpha particles consist of the nuclei, or cores, of helium atoms. The radiation was equivalent to a dose below 20 centiGrays.

A centiGray is a unit used in radiation measurement. The radiation employed in the study is considered low-level. Mine workers are occasionally exposed to such levels of radiation. People in radon-contaminated homes are rarely exposed to these levels. The risks of exposure to lower radiation levels are poorly understood and have been the subject of controversy for decades.

In the study, the researchers found that when they beamed alpha particles at only one in 10 cells, the results were almost the same as if they had be
'"/>

Contact: Annie Bayne
as862@columbia.edu
Columbia University Medical Center
11-Dec-2001


Page: 1 2 3

Related biology news :

1. Vioxx in high doses causes hypertension
2. PTEN and prostate cancer--the devil is in the doses
3. Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream
4. UT Southwestern researchers say overdoses of acetaminophen cause most cases of acute liver failure
5. Extended-release niacin effective in low doses for diabetics, say UT Southwestern researchers
6. Gel may cut doses for some medications
7. New evidence of radiation risk in childhood leukaemia
8. Chernobyl study: Risk of thyroid cancer rises with radiation dose
9. Many physicians misperceive radiation risks to developing fetuses from X-rays and CT scans
10. New insight into how tumors resist radiation
11. Ultraviolet irradiation in ventilation systems could reduce office sickness

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... February 26, 2020 , ... ... its patent-pending Rebound PRP™ and Rebound PRF® devices are now available to ... generation of regenerative medical devices, that will provide the most affordable, easiest ...
(Date:2/28/2020)... (PRWEB) , ... February 27, ... ... LLC (VIC), has formed Filtravate, its newest portfolio company. Established to develop ... on technology exclusively licensed from New Mexico State University (NMSU). The patent-pending ...
(Date:2/21/2020)... VIEW, Calif. (PRWEB) , ... February 20, 2020 ... ... sorting and dispensing platforms, announced today that it has entered into a collaboration ... single cell isolation on HepaTx’s unique hepatocyte-like cells (iHeps) developed from adipose tissue-derived ...
Breaking Biology News(10 mins):
(Date:2/3/2020)... Mass. (PRWEB) , ... February 03, 2020 , ... ... US offices in Cambridge, MA, announce that OmniType, the 11-locus, single tube multiplex ... today. OmniType is a best-in-class product featuring locus-multiplexing and short library preparation, for ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... solutions for biopharmaceutical R&D, today announced the release of Genedata Expressionist ... on supporting the implementation of Multi-Attribute Methods (MAM) for characterizing and monitoring ...
(Date:1/27/2020)... (PRWEB) , ... January 27, 2020 , ... ... advances in neuroscience and cloud and mobile computing, today announced the availability of ... across an organization to use the latest neuroscience of leadership and change research ...
(Date:1/24/2020)... ... 24, 2020 , ... The plastic and reconstructive surgeons at The Institute ... the notion that plastic surgery is much more than just cosmetic surgery and far ... the last 20 years NJ Top Docs, Dr. Andrew Elkwood, Dr. Michael Rose, Dr. ...
Breaking Biology Technology:
Cached News: